Presentation TCT 2018 REDUCE HTN: REINFORCE: A Sham-Controlled, Off-Med Randomized Trial of Renal Denervation for Treatment of Hypertension Presenter: John A. Bittl, Bernard J. Gersh, Michael A. Weber September 24, 2018
Presentation TCT 2018 Patient Perspectives on Sham-Controlled Trials Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Debbe McCall September 23, 2018
Presentation TCT 2018 FDA Perspectives on Sham-Controlled Trials Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Hiren Mistry September 23, 2018
Presentation TCT 2018 Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have? Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, David E. Kandzari September 23, 2018
Presentation TCT 2018 ORBITA One Year Later: What Would I Do Differently, If Anything? Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Rasha Al-Lamee September 23, 2018
Presentation TCT 2016 Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari October 30, 2016